Nathan Carberry is an Assistant Professor of Neurology at the University of Miami within the Neuromuscular Division. He is a clinician with a background in Bioengineering and with both clinical and research interest in ALS, electrodiagnostic medicine, and neuropathy. He serves as an investigator for several clinical trials in ALS and has previously investigated treatments for transthyretin amyloidosis neuropathy and Charcot-Marie Tooth. He initiated and currently manages the Neurology Department’s first genetic treatment intrathecal infusion clinic for ALS.